Abstract
There is an ongoing debate between whether or not it is ethical
for researchers to use placebos while studying terminal Illnesses.
Within this debate there are two parties, the party that believes
that it is ethical and the party that believes that it is not. Both
parties have many valid points and have very detailed arguments
against one another. When determining whether or not the use of
placebos is ethical or not, you must first understand what a
placebo is, and what the different types are. This paper goes
over what a placebo Is, what the different types are, and the
main points that each party has. This paper also goes over
whether or not the use of placebo is ethical. Of course every
person has their own ethical opinion.
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Aplacebo can be defined two different ways. A placebo is
usually a pharmacologically inert preparation prescribed more
for the mental retief of the patient than for its actual effect
on a disorder; or as an inert or Innocuous substance used
especially in controlled experiments testinll the efficacy of
another substance las a drug) (merriam-webster.com). There
are also two different types of placebos; there are inert
placebos and active placebos. An inert placebo does not have
any harmfulOf' beneficial corrsequeoce5 caused by its Hactive"
Ingredients. Inert placebos can superficially mimic the
Hactive" treatment by taste, shape and color. An active
placebo is specifically designed and used to mimic some of
the side effects of the intervention to further secure blinding
in a study (Edwards, Steverrs, Brauhottz, Liford, and Swift 1).
There has been a "renewed interest" in active placebos in
surgical trials. There 15 also a growing Interest for active
placebos In pharmacology as wetl. Placebos are now being
used in research studies that are conducted on trying to find a
cure for terminal illnesses. This brings up a strong ethical
question on whether or not researchers should use placebos
when treating terminally III patients. With every ethical
question there are two sides. There is a side that believes
that it is ethical and there is a side that believes that it is
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POSitives
• Placebos should be used because they give patients reassurance
and comfort (Miller, Colloca 40-41).
Placebos are ethical because they provide patients with
reassurance and comfort. Just the ritual of going to the doctors
and taking the medication can make them feel better. During
research on terminal illnesses, patients need to feel reassured
and comfortable or they could sway the reSUlts.
• Placebos can also provide beneficial treatment to patients
(Miller. CoHoca 43-44).
There are many treatments that are used that are placebos
that actually help the patients. Some treatments can 1nclude
vitamins for various patients' complaints, antibiotics for possible
viral infections and also acupuncture for certain types of chronic
pain (Miller, Colloca 40). Why should people be given all kinds of
medication, when there are other options that help? Placebos
are ethical because there are many other ways of helping a
patient than just prescribing medication to every patient's
ailment. Placebos have also proven to be almost or just as good
as "active" medication (BiIler·Andorno 45). With people now a
day's becoming so dependent on medication, using placebos are
a good way of helping people stay healthy.

• Placebos are used to help find new medication (De Zulueta 1112).
When researchers are trying to figure out if a new type of
treatment works better than the older one, they use placebos. For
this to work, the patient also has to be reassured that they are the
one lIetting the better treatment, even thoullh they may not.
Though this can be cornoidered lying to the patient and breaking
the sacred bond between the doctor and patient, they are doing It
for the better of everyone else. In randomized studies to
determine whether or not there is a new and better treatment to
breast cancer, women would sign up for the study, not to help
themselves, but to help all of the future women that get It (Bach,
2011). Therefore, using placebos is ethical because though it might
be hurtll1!l people now, they are using it to help people in the
future.

are not telling them the truth about the medication they are
taking. As soon as the patient learns about the placebo, they will
feel as thoullh they have been deceived by someone they shoutd
trust. When a patient Is being treated for a terminal IUness, trust
is especially vital as these patlenu are trusting doctors to save
their lives (Miller, Colloca 3). While It is wrong to lie about the
effectiveness of medication, it may be necessary for research. A
placebo can only be effective if the patient is unaware that it is a
placebo. Placebo effects can help determine whether a new
medication actually works or if it works because the patient wants
it to work. While the use of placebos may help cure a specific
terminal illness, it will often reqUire the doctor to be dishonest
with their patient (De Zulueta 1H2). Is it more important to cure
one patient flOW, or pursue the possibility of curing many in the
future?

Placebo treatment considered an option

• Some placebo trials withhold a superior treatment option for
patients (Biller-Andorno 6).
When random placebo-controlled trials were being used for
HN-positive pregnant women in developing countries, many
women were deprived 01 available treatment (De Zulueta 9).
These trials were doing more harm to individuals now than It
would help Individuats In the future because some women were
not getting the treatment that they deserved. if there is a
treatment that can save a woman and her unborn child's life, it
should be taken advantage of immediately.
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• Even if the cheaper treatmenu that they are testing for are
effective, some local governments refuse to use them (De
Zulueta 9,10).
In South Africa, a large number of pregnant women are
infected with HIV. Pharmaceutical companies are offering
treatment for these women at a reasonable cost. However, the
government will not implement this treatment due to possible
denial that HIV causes AIDS (De Zulueta 10).
• The use of placebos often leads to mistrust between a patient
and their physician (8i1ler-Andorno 6).
Once a patient discovers that they were given a placebo
Instead of actual treatment, they feel as though their physician
lied to them. Trust is extremely important for patients with
terminal illnesses. They are In an extremely vulnerable state and
put a lot of faith in the hands of their caregiver. If a particular
doctor Is witting to lie about the effectiveness of medication,
what else are they lying about?
• The use of placebos instead of actual treatment goes against the
duty of a physician (De Zulueta 11·14) .
Doctors have the duty to give the best care possible to
patients. According to the World Medical Association in the
Declaration of Helsinki, every patient should be assured of the
best possible diagnostic and therapeutic method (De Zulueta 12·
13). Since a placebo does nothing, it is not the best possible
method for a patient. It is unethical to knowingly give a patient
with a life·threatening ill~s something that will have no
h sical effect on their well·bein (De Zulueta 12).

Doctors don't only use sugar pills to give their patients a placebo
effect. Some use drugs for other purposes. If a doctor uses an
antibiotic as a placebo, the patient may benefit from its
bacteria·destroying abilities but also experience unnecessary
negative side effects (Miller, Colloca 3). Many people do not
a reciate lies. When a doctor ives a atient a lacebo th
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Conclusion
Doctors do not need to tie to patients in order to discover
whether a medication is effective or not. In order for the use of
placebos In terminal IlLnesses to be ethical, patients must give
consent. By simply telling research participants that they may
get medication or they may get a placebo, researchers can avoid
being dishonest without giving too much away (Miller, Cotloca 6).
These placebos should not have any benefit to a patient's health
In order to determine the true effects of the treatment. Placebo
trials can only be ethical if they do not deny available treatment
to patients. Terminally ill patients have the right to get
treatment if 1t is available to them. When used properly,
placebos can be extremely useful in research. While it Is the
duty of a physician to provide the best possible care to
Individuals, it is also the duty of researchers to discover
technology to help stop these illnesses from growing.
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